GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stratec SE (OTCPK:SBMDY) » Definitions » Valuation Rank

Stratec SE (Stratec SE) Valuation Rank


View and export this data going back to 2011. Start your Free Trial

What is Stratec SE Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Stratec SE Valuation Rank Related Terms

Thank you for viewing the detailed overview of Stratec SE's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Stratec SE (Stratec SE) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stratec SE (OTCPK:SBMDY) » Definitions » Valuation Rank
Comparable Companies
XTER:EUZ XTER:GME XTER:AAQ1 ABT SYK BSX MDT XTER:SHL EW DXCM SZSE:300760 XAMS:PHIA ZBH STE ALGN XSWX:SOON SHSE:688271 ASX:COH PODD SWAV
Traded in Other Exchanges
0RAR:UK SBS:Germany
Address
Gewerbestrasse 37, Birkenfeld, RP, DEU, 75217
Website
https://www.stratec.com
Stratec SE designs and manufactures automated analyzer systems for laboratory data management and solutions for molecular diagnostic sample preparation and stabilization. Its business segments are Instrumentation, Diatron and Smart Consumables. Its Instrumentation segment is engaged in designing and manufacturing automated analyzer systems for clinical diagnostics and biotechnology customers. The Diatron segment comprises the business with systems, system components, consumables, and tests in the low throughput hematology and clinical chemistry segment. Its Smart Consumables segment is engaged in developing and selling scientific materials, such as nucleic acid purification. The company generates maximum revenue from the Instrumentation segment.